BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 2111794)

  • 1. Asialoagalacto-choriongonadotropin, an antagonist of the action of Graves' immunoglobulins in human thyroid membranes with a limited affinity for hepatic receptors.
    Hoermann R; Rehbach K; Mann K
    Horm Metab Res; 1990 Mar; 22(3):196-7. PubMed ID: 2111794
    [No Abstract]   [Full Text] [Related]  

  • 2. Asialoagalacto-human chorionic gonadotropin, a carbohydrate-modified variant of human chorionic gonadotropin, antagonizes the stimulatory actions of bovine thyroid-stimulating hormone on thyroid function and HLA-DR expression in human thyroid in vitro and in vivo.
    Hoermann R; Schumm-Draeger PM; Rehbach K; Mann K
    J Clin Invest; 1991 Dec; 88(6):1947-54. PubMed ID: 1752954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Precipitation of the thyrotropin receptor and identification of thyroid autoantigens using Graves' disease immunoglobulins.
    Heyma P; Harrison LC
    J Clin Invest; 1984 Sep; 74(3):1090-7. PubMed ID: 6088581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of tsh binding inhibiting antibodies (TBI-ab) and thyroid adenylate cyclase stimulating antibodies (TS-ab) in sera of patients with Graves' disease.
    Lattanzi V; Scardapane R; Ciampolillo A; Vincenti C; Giorgino R
    Boll Soc Ital Biol Sper; 1985 Jan; 61(1):55-60. PubMed ID: 3838478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the thyrotropin receptor and its involvement in Graves' disease.
    Kohn LD
    Horiz Biochem Biophys; 1977; 3():123-63. PubMed ID: 69601
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of desialylation on the in vitro interaction of human chorionic gonadotropin with human thyroid plasma membranes.
    Amir SM; Sullivan R; Ingbar SH
    Endocrinology; 1981 Oct; 109(4):1203-11. PubMed ID: 7285869
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of the thyroid adenylate cyclase response to thyroid-stimulating immunoglobulin G by crude and asialo-human chorionic gonadotropin.
    Uchimura H; Nagataki S; Ito K; Amir SM; Ingbar SH
    J Clin Endocrinol Metab; 1982 Aug; 55(2):347-53. PubMed ID: 6123521
    [No Abstract]   [Full Text] [Related]  

  • 8. TSH binding by globulins from patients with Graves' disease.
    Bíró J
    Endocrinol Exp; 1981; 15(2):145-53. PubMed ID: 6114853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The thyroid "microsomal" antigen is an epitope on the thyrotropin receptor.
    Islam N; Tuppal R; Hawe BS; Briones-Urbina R; Farid NR
    J Cell Biochem; 1986; 31(2):107-20. PubMed ID: 2426288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial characterization and clinical correlation of circulating human immunoglobulins directed against thyrotrophin binding sites in guinea pig fat cell membranes. Development of a direct enzyme immunoassay.
    Baker JR; Lukes YG; Smallridge RC; Berger M; Burman KD
    J Clin Invest; 1983 Oct; 72(4):1487-97. PubMed ID: 6138364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between exophthalmogenic and thyroid-stimulating immunoglobulins in Graves' endocrine ophthalmopathy.
    Leövey A; Kálmán K; Szabó T; Lente K; Sándor P; Balázs C
    Acta Med Acad Sci Hung; 1980; 37(4):345-50. PubMed ID: 6263033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a human monoclonal antibody from a Graves' disease patient that identifies a novel thyroid membrane antigen.
    Baker JR; Saunders NB; Kaulfersch W; Burman KD
    J Immunol; 1988 Apr; 140(8):2593-9. PubMed ID: 2895790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new method for measurement of human thyroid-stimulating immunoglobulins.
    Kleinmann RE; Braverman LE; Vagenakis AG; Butcher RW; Clark RB
    J Lab Clin Med; 1980 Apr; 95(4):581-9. PubMed ID: 6244354
    [No Abstract]   [Full Text] [Related]  

  • 14. Interaction of lymphocytes and thyrocytes in Graves' disease and nonautoimmune thyroid diseases in immunohistochemical and ultrastructural investigations.
    Ben-Skowronek I; Sierocinska-Sawa J; Szewczyk L; Korobowicz E
    Horm Res; 2009; 71(6):350-8. PubMed ID: 19506393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid xenografts from patients with Graves' disease in severe combined immunodeficient mice and NIH-beige-nude-xid mice.
    Mukuta T; Arreaza G; Nishikawa M; Resetkova E; Jamieson C; Tamai H; Volpé R
    Clin Invest Med; 1997 Feb; 20(1):5-15. PubMed ID: 9013039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The adenylate cyclase-cyclic AMP system in Graves' disease.
    Field JB; Muto H; Chou MC
    Adv Cyclic Nucleotide Res; 1980; 12():359-72. PubMed ID: 6250367
    [No Abstract]   [Full Text] [Related]  

  • 17. Cell-mediated immunity in the exophthalmos of Graves' disease as demonstrated by the migration inhibition factor (MIF) test.
    Munro RE; Lamki L; Row VV; Volpé R
    J Clin Endocrinol Metab; 1973 Aug; 37(2):286-92. PubMed ID: 4740520
    [No Abstract]   [Full Text] [Related]  

  • 18. Binding of thyroglobulin and thyroglobulin-antithyroglobulin immune complex to extraocular muscle membrane.
    Konishi J; Herman MM; Kriss JP
    Endocrinology; 1974 Aug; 95(2):434-46. PubMed ID: 4136562
    [No Abstract]   [Full Text] [Related]  

  • 19. New simple and sensitive method of estimation of anti-thyroid-plasma-membranes antibodies in serum of patients with autoimmune thyroid diseases.
    Gardas A; Czarnocka B; Nauman J
    Endokrynol Pol; 1982; 33(4-6):295-301. PubMed ID: 6897889
    [No Abstract]   [Full Text] [Related]  

  • 20. Interference of thyroglobulin in TSab detection by radio-receptor assay.
    Fenzi GF; Bartalena L; Macchia E; Monzani F; Checchi M
    J Endocrinol Invest; 1979; 2(2):221-2. PubMed ID: 582828
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.